Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
328
-
Total 13F shares, excl. options
-
124M
-
Shares change
-
-10.3M
-
Total reported value, excl. options
-
$5.5B
-
Value change
-
-$445M
-
Put/Call ratio
-
0.4
-
Number of buys
-
138
-
Number of sells
-
-172
-
Price
-
$44.23
Significant Holders of IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) as of Q3 2022
400 filings reported holding IONS - IONIS PHARMACEUTICALS INC - COMMON STOCK as of Q3 2022.
IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) has 328 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 124M shares
of 159M outstanding shares and own 78.49% of the company stock.
Largest 10 shareholders include FMR LLC (21.3M shares), VANGUARD GROUP INC (12.8M shares), T. Rowe Price Investment Management, Inc. (11.2M shares), Bellevue Group AG (9.46M shares), BlackRock Inc. (8.94M shares), Clearbridge Investments, LLC (5.77M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.8M shares), STATE STREET CORP (3.76M shares), ARK Investment Management LLC (3.71M shares), and BVF INC/IL (2.87M shares).
This table shows the top 328 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.